Heidelberg Pharma AG's total assets for Q3 2024 were €65.77M, a decrease of -8.61% from the previous quarter. DE:HPHA total liabilities were €29.95M for the fiscal quarter, a -2.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.